In conclusion, we characterized the gut mycobiome of HCC patients and demonstrated that the abnormal colonization of C. albicans in the gut changed HCC metabolism and contributed to the progression of HCC depending on NLRP6, providing new targets for the treatment of HCC. The gene discussed is NLRP6; the disease is hepatocellular carcinoma.